These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8156846)

  • 1. [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale].
    Shi YS; Liu JH; Yu XZ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):229-31. PubMed ID: 8156846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
    Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M
    Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of prostaglandin E1 in treatment of cor pulmonale patients with heart failure].
    Zhou SC; Wang W; Hu Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Apr; 20(2):88-90. PubMed ID: 10072831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of the presence of digoxin-like immunoreactive substance (DLIS) in the serum and urine in children with nephrotic syndrome.
    Shimabukuro N; Ebara H; Maruyama K; Tomizawa S; Kuroume T
    Clin Nephrol; 1988 May; 29(5):244-7. PubMed ID: 2840225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
    Heise HR; Vorwerk P; Fritsche K; Richter R
    Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in serum endogenous digoxin-like substances in cirrhotic patients treated by ultrafiltration of ascites and reinfusion].
    Yang J
    Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):329-30. PubMed ID: 1667498
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of changes in the serum level of endogenous digitalis-like factor in patients with chronic congestive heart failure].
    Ko YS; Yang SY; Yian WK
    Zhonghua Nei Ke Za Zhi; 1990 Jan; 29(1):11-3, 59-60. PubMed ID: 2169387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin-like immunoreactive substance in renal transplant patients.
    Schrader BJ; Maddux MS; Veremis SA; Mozes MF; Maturen A; Bauman JL
    J Clin Pharmacol; 1991 Dec; 31(12):1126-31. PubMed ID: 1662232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endogenous digoxin-like factor: serum concentration and interrelations with the electrolyte picture in normal subjects].
    Andronico G; Mangano MT; Carone MB; Cerasola G
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1053-8. PubMed ID: 2560923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous glycosides in critically ill patients.
    Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
    Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of digoxin-like immunoreactive factor (DLIF) for intensive care medicine].
    Simon HB; Behrendt W; Stein T
    Anasth Intensivther Notfallmed; 1990 Jun; 25(3):235-6. PubMed ID: 2168132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endogenous digoxin-like factor in myocardial infarction].
    Bagrov AI; Kuznetsova EA; Fedorova OV
    Klin Med (Mosk); 1996; 74(4):15-7. PubMed ID: 8999142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
    Lackner TE; Lau BW; Parvin C; Valdes R
    Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-like immunoreactive substance in serum of preterm and full-term neonates.
    Bertrand JM; Langhendries JP; Gras A; Battisti O
    Eur J Pediatr; 1987 Mar; 146(2):145-6. PubMed ID: 3032639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose.
    Yang SS; Hughes RD; Williams R
    Hepatology; 1988; 8(1):93-7. PubMed ID: 2828215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hypotensive effect of calcium antagonists and endogenous digitalis-like immunoreactivity in human essential hypertension.
    Palombo C; Marabotti C; Genovesi-Ebert A; Del Chicca MG; Balzan S; Giaconi S; Fommei E; Gazzetti P; Clerico A; Ghione S
    J Hypertens Suppl; 1986 Dec; 4(5):S461-4. PubMed ID: 3033184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in serum endogenous digitalis-like factor concentration in patients with renal impairment].
    Ke YS; Tao YY; Yang SY
    Zhonghua Nei Ke Za Zhi; 1992 Apr; 31(4):223-5, 255. PubMed ID: 1330455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
    Li JH; Wu ZG; Xu JQ; Zhou Y
    Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.